Browse > Article
http://dx.doi.org/10.4142/jvs.2021.22.e78

Successful treatment of recurrent subclinical mastitis in cows caused by enrofloxacin resistant bacteria by means of the sequential intramammary infusion of enrofloxacin HCl-2H2O and ceftiofur HCl: a clinical trial  

Alfonseca-Silva, Edgar (Department of Microbiology and Immunology, School of Veterinary Medicine, National Autonomous University of Mexico)
Cruz-Villa, Juan Carlos (Department of Microbiology and Immunology, School of Veterinary Medicine, National Autonomous University of Mexico)
Gutierrez, Lilia (Department of Physiology and Pharmacology, School of Veterinary Medicine, National Autonomous University of Mexico)
Sumano, Hector (Department of Physiology and Pharmacology, School of Veterinary Medicine, National Autonomous University of Mexico)
Publication Information
Journal of Veterinary Science / v.22, no.6, 2021 , pp. 78.1-78.10 More about this Journal
Abstract
Background: Recurrent subclinical mastitis (RScM) due to resistant bacteria has low clinical and bacteriological cure rates, often requiring the culling of cows. The sequential intramammary administration of enrofloxacin hydrochloride-dihydrate (enro-C) followed by ceftiofur HCl may be useful for treating these cases. Objectives: This study assessed the bacteriological and clinical cure-efficacies of the sequentially intramammary administration of enro-C, followed by ceftiofur HCl to treat RScM in Holstein/Friesian cows. Methods: This trial was conducted in a herd with a high prevalence of RScM, and 20 Holstein/Friesian cows were included: 45% suffering subclinical mastitis and 38.9% of the mammary quarters affected. Twenty-nine bacterial isolates in vitro resistant to enro-C were obtained (coagulase-negative Staphylococcus spp, 55.2%; Staphylococcus aureus, 27.6%; Escherichia coli, 6.9%; Streptococcus uberis, 6.9%; Corynebacterium bovis, 3.4%). Polymerase chain reaction-isolated the following genes linked to enro-C resistance: chromosomal (gyrA) and plasmid (aac(6')-lb-cr). The treatments were as follows: twice-daily intramammary infusions of enro-C (300 mg/10 mL) for 5 days. Cows clinically considered treatment failures were also treated with intramammary ceftiofur (125 mg/10 mL, twice daily for 5 days. The clinical and bacteriological cure rates were carried out when completing each treatment phase and at 14 and 21 days, aided by a California mastitis test, somatic cell count, and failure to identify the initially causative bacteria. Results: Enro-C achieved 65% clinical and bacteriological cure rates, and 100% cure rates were obtained after the rescue treatment with ceftiofur HCl. Conclusions: Outstanding clinical and bacteriological cure rates in cows affected by RScM were achieved with the consecutive intramammary infusions of enro-C, followed by ceftiofur HCl.
Keywords
Fluoroquinolone; mastitis; bovine; bacterial-resistant;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Sumano H, Ocampo L, Tapia G, Mendoza CJ, Gutierrez L. Pharmacokinetics of enrofloxacin HCl-2H 2 O (Enro-C) in dogs and pharmacokinetic/pharmacodynamic Monte Carlo simulations against Leptospira spp. J Vet Sci. 2018;19(5):600-607.   DOI
2 Suojala L, Simojoki H, Mustonen K, Kaartinen L, Pyorala S. Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis. J Dairy Sci. 2010;93(5):1960-1969.   DOI
3 Kaartinen L, Salonen M, Alli L, Pyorala S. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. J Vet Pharmacol Ther. 1995;18(5):357-362.   DOI
4 Ocampo PS, Lazar V, Papp B, Arnoldini M, Abel zur Wiesch P, Busa-Fekete R, et al. Antagonism between bacteriostatic and bactericidal antibiotics is prevalent. Antimicrob Agents Chemother. 2014;58(8):4573-4582.   DOI
5 Owens WE, Nickerson SC, Ray CH. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation. J Dairy Sci. 1999;82(3):645-647.   DOI
6 Sharma N, Singh NK, Bhadwal MS. Relationship of somatic cell count and mastitis: an overview. AsianAustralas J Anim Sci. 2011;24(3):429-438.
7 Jimenez Mejia R, Gudino Sosa LF, Aguilar Lopez JA, Loeza Lara PD. Molecular characterization of antibiotic resistant Escherichia coli isolated from bovine mastitis in Michoacan, Mexico. Rev Mex Cienc Pecu. 2017;8(4):387-396.   DOI
8 Mendoza J, Gutierrez L, Gutierrez JA, Bustos FA, Sumano H. Pharmacokinetics of enrofloxacin HCl-2H2 O (ENRO-C), PK/PD, and Monte Carlo modeling vs. Leptospira spp. in cows. J Vet Pharmacol Ther. 2019;42(3):300-308.   DOI
9 Yang B, Lei Z, Zhao Y, Ahmed S, Wang C, Zhang S, et al. Combination susceptibility testing of common antimicrobials in vitro and the effects of sub-MIC of antimicrobials on Staphylococcus aureus biofilm formation. Front Microbiol. 2017;8:2125.   DOI
10 Carter GR, Cole JR. Diagnostic Procedure in Veterinary Bacteriology and Mycology. 5th ed. Cambridge: Academic Press; 1990.
11 Galfi A, Radinovic M, Milanov D, Bobos S, Pajic M, Savic S, et al. Electrical conductivity of milk and bacteriological findings in cows with subclinical mastitis. J Anim Sci Biotechnol. 2015;31(4):533-541.
12 Krishnamoorthy P, Satyanarayana ML, Shome BR. Coagulase negative Staphylococcal species mastitis: an overview. Res J Vet Sci. 2016;9(1):1-10.
13 Pyorala S, Taponen S. Coagulase-negative staphylococci-emerging mastitis pathogens. Vet Microbiol. 2009;134(1-2):3-8.   DOI
14 Majlesi A, Kakhki RK, Mozaffari Nejad AS, Mashouf RY, Roointan A, Abazari M, et al. Detection of plasmid-mediated quinolone resistance in clinical isolates of Enterobacteriaceae strains in Hamadan, West of Iran. Saudi J Biol Sci. 2018;25(3):426-430.   DOI
15 Chavez-Jacobo VM, Ramirez-Diaz MI, Silva-Sanchez J, Cervantes C. Resistencia bacteriana a quinolonas: determinantes codificados en plasmidos. Rev Educ Bioquim. 2015;34(1):4-9.
16 Ruegg PL. A 100-year review: mastitis detection, management, and prevention. J Dairy Sci. 2017;100(12):10381-10397.   DOI
17 Izquierdo AC, Liera JEG, Cervantes RE, Castro JFI, Mancera EAV, Crispin RH, et al. Production of milk and bovine mastitis. J Adv Dairy Res. 2017;5(2):1-4.
18 Ashraf A, Imran M. Diagnosis of bovine mastitis: from laboratory to farm. Trop Anim Health Prod. 2018;50(6):1193-1202.   DOI
19 Kumari T, Bhakat C, Choudhary RK. A review on sub clinical mastitis in dairy cattle. Int J Pure Appl Biosci. 2018;6(2):1291-1299.
20 Ciesielczuk H, Hornsey M, Choi V, Woodford N, Wareham DW. Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants. J Med Microbiol. 2013;62(Pt 12):1823-1827.   DOI
21 Qin T, Qian H, Fan W, Ma P, Zhou L, Dong C, et al. Newest data on fluoroquinolone resistance mechanism of Shigella flexneri isolates in Jiangsu Province of China. Antimicrob Resist Infect Control. 2017;6(1):97.   DOI
22 Correia S, Poeta P, Hebraud M, Capelo JL, Igrejas G. Mechanisms of quinolone action and resistance: where do we stand? J Med Microbiol. 2017;66(5):551-559.   DOI
23 Persson Y, Katholm J, Landin H, Mork MJ. Efficacy of enrofloxacin for the treatment of acute clinical mastitis caused by Escherichia coli in dairy cows. Vet Rec. 2015;176(26):673.   DOI
24 Gutierrez L, Miranda-Calderon JE, Garcia-Gutierrez P, Sumano H. Physicochemical characterization and pharmacokinetics in broiler chickens of a new recrystallized enrofloxacin hydrochloride dihydrate. J Vet Pharmacol Ther. 2015;38(2):183-189.   DOI
25 Sayeed MA, Rahman MA, Bari MS, Islam A, Rahman MM, Hoque MA. Prevalence of subclinical mastitis and associated risk factor at cow level in dairy farms in Jhenaidah. Adv Anim Vet Sci. 2020;8(2):112-121.
26 Royster E, Wagner S. Treatment of mastitis in cattle. Vet Clin North Am Food Anim Pract. 2015;31(1):17-46.   DOI
27 Martinez PD, Cruz CA, Moreno FG. Resistance of causing bacteria of bovine mastitis in regard to common antimicrobials. Conexion Agropecuaria JDC. 2013;3(1):53-73.
28 de Almeida IC, Viana MVG, Dietrich WS, Clipes RC, Donatele DM, Martins IVF, et al. Economic impact of bovine mastitis in Espirito Santo, Brazil. Int J Dev Res. 2021;11(2):44315-44319.
29 Hillerton JE, Semmens JE. Comparison of treatment of mastitis by oxytocin or antibiotics following detection according to changes in milk electrical conductivity prior to visible signs. J Dairy Sci. 1999;82(1):93-98.   DOI
30 Blondeau JM, Fitch SD. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis. PLoS One. 2019;14(1):e0210154.   DOI
31 Kulkarni AG, Kaliwal BB. Bovine mastitis: a review. Int J Recent Sci Res. 2013;4(5):543-548.
32 Birhanu M, Leta S, Mamo G, Tesfaye S. Prevalence of bovine subclinical mastitis and isolation of its major causes in Bishoftu Town, Ethiopia. BMC Res Notes. 2017;10(1):767.   DOI
33 Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother. 2006;50(11):3953-3955.   DOI
34 Truchetti G, Bouchard E, Descoteaux L, Scholl D, Roy JP. Efficacy of extended intramammary ceftiofur therapy against mild to moderate clinical mastitis in Holstein dairy cows: a randomized clinical trial. Can J Vet Res. 2014;78(1):31-37.
35 Schalm OW, Noorlander DO. Experiments and observations leading to development of the California mastitis test. J Am Vet Med Assoc. 1957;130(5):199-204.
36 Viveros M, Lopez-Ordaz R, Gutierrez L, Miranda-Calderon JE, Sumano H. Efficacy assessment of an intramammary treatment with a new recrystallized enrofloxacin vs ceftiofur and parenteral enrofloxacin in dairy cows with nonsevere clinical mastitis. J Vet Pharmacol Ther. 2018;41(1):e1-e9.   DOI
37 Procedure for Collecting Milk Samples [Internet]. New Prague: National Mastitis Council; http://www.nmconline.org. Update 2004. Accessed 2020 Oct 26.
38 Oram M, Kuroda R, Fisher LM. Escherichia coli DNA gyrase: genetic analysis of gyrA and gyrB mutations responsible for thermosensitive enzyme activity. FEBS Lett. 1992;312(1):61-65.   DOI